Skip to main content

Table 4 Clinical features of RP and NRP patients with COVID-19

From: Atypical presentations of coronavirus disease 2019 (COVID-19) from onset to readmission

Features

NRP patients (n=72)

RP patients(n=7)

P-value

Sex

 Male#

40(55. 6%)

4(57.1%)

0.751a

 Female#

32(44.4%)

3(42.9%)

 

Age

41.9±13.8

41.0±19.8

0.880b

Course of disease

2.50±2.58

2.43±2.82

0.950b

Clinical types

  

0.604c

 Mild#

10(13.9%)

1(14.3%)

 

 Moderate#

55(76.4%)

6(85.7%)

 

 Severe#

7(9.70%)

0(0.0%)

 

Symptoms

  

1.00a

 Symptomatic#

63(87.5%)

6(85.7%)

 

 Asymptomatic#

9(12.5%)

1(14.3%)

 

Hospitalization days

15.8±6.86

18.3±5.35

0.357b

Days of last RNA negative-conversion

12.4±6.58

15.3±5.38

0.270b

Days of last RNA negative-conversion category

 

0.096c

 < 7 days#

10(13.9%)

0(0.0%)

 

 7 days to 14 days#

40(55.6%)

3(42.8%)

 

 14 days to 21 days#

19(26.4%)

3(42.9%)

 

 > 21 days#

3(4.1%)

1(14.3%)

 

WBC count (× 109/L)

5.28±2.30

7.07±3.29

0.062b

Lymphocyte count

1.32±0.86

1.22±0.38

0.763b

Lymphocyte rate (%)

25.6±11.4

21.0±10.4

0.313b

Neutrophil count(×109/L)

3.48±2.01

5.14±3.23

0.228b

Neutrophil rate (%)

64.4±14.3

63.9±17.6

0.931b

  1. Note:*Data with statistical significance. #Results are measurements with corresponding ratio in parentheses, and the remainder results are mean value with standard deviation. Pa: chi square test, Pb: student’s t test, Pc: Kruskal-Wallis H test, WBC White blood cell